Answers are grounded in this paper and cite their sources.
Hormonal therapy occasionally produces long-term survival of men with metastatic carcinoma of the prostate. To identify which patients will benefit for long intervals a retrospective analysis was done on 56 men with stage D carcinoma of the prostate treated between 1963 and 1968. Of this group 5 patients lived longer than 10 years. We were unable to identify clinical or pathologic characteristics that would have indicated which patients would have done well.
No takes yet. Share an insight, caveat, or question.
Reiner et al. (1979) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: